Most Read This Week
- Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression
- De-Escalated Neoadjuvant Weekly Nab-Paclitaxel With Trastuzumab and Pertuzumab vs Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab for HER2-Positive Early Breast Cancer
- San Antonio Breast Cancer Symposium, Dec. 10 to 13
- The Efficacy of Continuing Osimertinib With Platinum Pemetrexed Chemotherapy Upon Progression in Patients With Metastatic NSCLC Harboring Sensitizing EGFR Mutations
- Invasive Disease–Free Survival Outcomes With SLNB vs Omission of Axillary Surgery in Patients With Early-Stage Breast Cancer Treated With Breast-Conserving Surgery
Recently Updated
- Risk for Head and Neck Cancer Lower for Coffee and Tea Drinkers
- Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression
- Early-Onset CRC Incidence Rates Increased in 27 of 50 Countries, Territories
- Disparities Seen in Biennial Mammography Screening for Women in in Their 40s
- Immune and Gene-Expression Profiling in Estrogen Receptor–Low and –Negative Early Breast Cancer